Boston Scientific has received the CE Mark for the Precision Plus Spinal Cord Stimulator System, a rechargeable SCS device. The system provides peripheral nerve stimulation for patients with chronic ...
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
At least 116 million US adults suffer from chronic pain at a annual cost of $560 to $635 billion in direct medical treatment costs and lost productivity, according to the Institute of Medicine (US) ...
The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...
The suits cite the U.S. Supreme Court’s 2024 decision in Loper Bright Enterprises v. Rainmondo in naming the FDA as a defendant. The lawsuits allege the devices should require pre-market approval ...
Patients are suing medical device makers for selling spinal cord stimulators to treat chronic back pain but allegedly triggered worsening pain and electric shocks. The complaints, however, will face a ...